Workflow
Mint Incorporation Limited Announces Pricing of $7 million Initial Public Offering and Listing on Nasdaq
GlobeNewswire· 2025-01-08 22:15
Hong Kong, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (Nasdaq: MIMI) (the “Company”), a Hong Kong-based interior design and fit out works provider, today announced the pricing of its initial public offering (the “Offering”) of 1,750,000 Class A ordinary shares (the “Class A Ordinary Shares”), at a price of $4.00 per Class A Ordinary Share (the “Offering Price”). The Class A Ordinary Shares are expected to begin trading on the Nasdaq Capital Market on January 10, 2025 under the symbol “MIMI ...
AM Best Upgrades the Financial Strength Ratings for Employers Holdings, Inc.'s Operating Subsidiaries to “A” (Excellent)
GlobeNewswire News Room· 2025-01-08 22:15
RENO, Nev., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Employers Holdings, Inc. (NYSE:EIG), a leading provider of workers’ compensation insurance, is pleased to announce that AM Best has upgraded the Financial Strength Rating (FSR) of each of its insurance companies to A (Excellent) from A- (Excellent) and their Long-Term Issuer Credit Ratings (Long-Term ICR) to “a” (Excellent) from “a-” (Excellent). Concurrently, AM Best has upgraded the Long-Term ICR of Employers Holdings, Inc. to “bbb” (Good) from “bbb-” (Good). ...
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
GlobeNewswire· 2025-01-08 22:15
Avid Urges Stockholders to Vote FOR the Pending Transaction TODAYTUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today posted an investor presentation in connection with its pending transaction with GHO Capital Partne ...
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire· 2025-01-08 22:13
BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a clinical-stage precision medicine company unlocking to advance transformational therapies, today announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 11:30 a.m. PT. About Frontier Medicines Frontier Medicines is a clinical stage pre ...
Kimco Realty® Expands Florida Presence with Acquisition of The Markets at Town Center
Newsfilter· 2025-01-08 22:08
– Grocery-Anchored Center in Core Market Acquired through the Company's Structured Investment Program – JERICHO, NY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE:KIM) a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, announced the acquisition of The Markets at Town Center, a 254,000-square-foot premier asset in Jacksonville, Florida for $108 million. The acquisition marks t ...
Kimco Realty® Expands Florida Presence with Acquisition of The Markets at Town Center
GlobeNewswire· 2025-01-08 22:08
– Grocery-Anchored Center in Core Market Acquired through the Company’s Structured Investment Program – JERICHO, NY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM) a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, announced the acquisition of The Markets at Town Center, a 254,000-square-foot premier asset in Jacksonville, Florida for $108 million. The acquisition marks ...
REGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit
GlobeNewswire· 2025-01-08 22:07
SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”), have until March 10, 2025 to seek appointment as lead plaintiff of the Regeneron class action lawsuit. Captioned Radtke v. Regeneron Pharmaceuticals, Inc., No. 25-cv-00145 (S.D.N.Y.), the Regeneron class action lawsuit charges Regeneron and certain of Reg ...
Concrete Pumping Holdings Reports Fourth Quarter and Fiscal Year 2024 Results
Newsfilter· 2025-01-08 22:05
DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) (the "Company" or "CPH"), a leading provider of concrete pumping and waste management services in the U.S. and U.K., reported financial results for the fourth quarter and fiscal year ended October 31, 2024. Fourth Quarter Fiscal Year 2024 Summary vs. Fourth Quarter of Fiscal Year 2023 (where applicable)  ●Revenue of $111.5 million compared to $120.2 million. ●Gross profit of $46.2 million compared to $48.9 million. ●Inco ...
Concrete Pumping Holdings Reports Fourth Quarter and Fiscal Year 2024 Results
GlobeNewswire· 2025-01-08 22:05
DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the "Company" or "CPH"), a leading provider of concrete pumping and waste management services in the U.S. and U.K., reported financial results for the fourth quarter and fiscal year ended October 31, 2024. Fourth Quarter Fiscal Year 2024 Summary vs. Fourth Quarter of Fiscal Year 2023 (where applicable) ●Revenue of $111.5 million compared to $120.2 million. ●Gross profit of $46.2 million compared to $48.9 million. ●Inc ...
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
Prnewswire· 2025-01-08 22:03
BOSTON, Jan. 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, February 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 6, 2025. The call can be accessed via teleconference at: Q3 2025 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will ...